期刊文献+

千层纸素诱导人慢性粒细胞白血病K562的凋亡作用 被引量:2

Apoptosis induction of oroxylin A in human chronic myelogenous leukemia cell line K562
下载PDF
导出
摘要 探讨千层纸素对人慢性粒细胞白血病细胞K562的凋亡诱导作用及其可能机制。采用MTT法检测细胞存活率;电镜下观察细胞超微结构的改变;DAPI染色观察细胞凋亡;流式细胞仪检测细胞凋亡率;Western blot法分析凋亡相关蛋白caspase 9、survivin及ERK1/2的表达变化情况。结果表明千层纸素呈浓度依赖地抑制K562细胞的增殖作用,诱导K562细胞发生凋亡,上调K562细胞中cleaved-caspase 9蛋白,下调survivin、pro-caspase 9及p-ERK1/2蛋白的表达水平。千层纸素可诱导K562凋亡,这可能与下调survivin蛋白表达,激活caspase 9蛋白,抑制ERK信号通路有关。 To investigate the apoptotic effect of oroxylin A on human chronic myelogenous leukemia cell line K562 and its potential mechanism. K562 cells were treated with oroxylin A. MTr assay was performed to assess growth inhibition effect of oroxylin A on K562 cells. The morphological change of cells were observed under electronic microscope. DAPI staining and flow cytometry were employed to observe the apoptosis rate of K562 cells. Changes in the expression of caspase 9, survivin and ERK1/2 were analyzed by Western blotting. Results showed that oroxylin A inhibited the growth of K562 in a time and dose-dependent manner. Oroxylin A induced cell apoptosis was characterized by appearance of numerous engorged vacuoles, reduction of microvilli on cell surface, condensation of chromatin and emergence of apoptotic body. Besides, oroxylin A dose-dependently induced K562 cell apoptosis, up-regulated the expression of cleaved-caspase 9 and down-regulated expression of survivin, pro-caspase 9 and p-ERK1/2 proteins. In conclusion, all these results showed that oroxylin A can induce apoptosis of K562 inhibition of cells, which might be related to the down-regulation of survivin expression, activation of caspase 9 and ERK signaling pathway
出处 《中国药科大学学报》 CAS CSCD 北大核心 2014年第2期232-236,共5页 Journal of China Pharmaceutical University
基金 国家"重大新药创制"科技重大专项资助项目(No.2012ZX09103101-050) 国家自然科学基金资助项目(No.81373448 No.81173086)~~
关键词 千层纸素 人慢性粒细胞白血病 凋亡 抗肿瘤活性 oroxylin A chronic myelogenous leukemia apoptosis antitumor activity
  • 相关文献

参考文献13

  • 1Wong RS, Cheong SK. Leukaemic stem cells: drug resistance, metastasis and therapeutic implications [ J ]. Malaysian J Pathol, 2012, 34(2) :77 -88.
  • 2Junia V. Melo,Timothy P. Hughes, et al. Chronic myeloid leuke- mia [ J ]. Hematology,2003.
  • 3Kusio-Kobialka M, Podszywalow-Bartnicka P, Peidis P, et al. The PERK-eIF2ct phosphorylation arm is a pro-survival pathway of BCR-ABL signaling and confers resistance to imatinib treatment in chronic myeloid leukemia cells [ J ]. Cell Cycle,2012,11 ( 21 ) :4 069 -4 078.
  • 4Gao Y, Lu N, Ling Y, et al. Oroxylin A inhibits angiogene- sis through blocking vascular endothelial growth factor-induced KDR/Flk-1 phosphorylation[ J]. J Cancer Res Clin Oncol,2009, 136 (5) :667 - 675.
  • 5Li HN, Nie FF, Liu W, et al. Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo [ J ]. Toxicology,2009,257 ( 1/2 ) : 80 - 85.
  • 6Zhu B,Zhao L,Zhu L,et al. Oroxylin A reverses CAM-DR of HepG2 cells by suppressing Integrinβl and its related pathway [ J ]. Toxicol Appl Pharmacol,2012,259 ( 3 ) :387 - 394.
  • 7Yang HY, Zhao L, Yang Z, et al. Oroxylin a reverses multi-drug resistance of human hepatoma BEL7402/5-FU ceils via downreg- ulation of P-glycoprotein expression by inhibiting NF-KB signa- ling pathway [ J ]. Molecular Carcinogenesis, 2012,51 ( 2 ) : 185 - 195.
  • 8Sun Y, Lu N, Ling Y, et al. Oroxylin A suppresses invasion through down-regulating the expression of matrix metalloprotein- ase-2/9 in MDA-MB-435 human breast cancer cells [ J ]. Eur J Pharmacol,2009,603 ( 1/2/3 ) :22 - 28.
  • 9Zhu L, Zhao L, Wang H, et al. Oroxylin A reverses P-glycopro- tein-mediated multidrug resistance of MCF'//ADR ceils by G2/M arrest[ J]. Toxicol Lett ,2013,219 (2) : 107 - 115.
  • 10Yao J, Hu R, Sun J, et al. Oroxylin A prevents inflammation-relat- ed tumor through down-regulation of inflammatory gene expres- sion by inhibiting NF-KB signaling[ J]. Mol Carcinog,2014,53 (2) : 145 - 58. doi : 10. 1002/mc. 21958.

同被引文献35

  • 1Ito S,Inoue S.Sophorolipids from Torulopsis bombicola:possible relation to alkane uptake [J].Appl Environ Microbial,1982,43:1278-1283.
  • 2Mulligan CN,Yong RN,Gibbs BF.Removal of heavy metals from contaminated soil and sediments using the biosurfactant surfactin [J].J Soil Contam,1999,8:231-254.
  • 3Mulligan CN,Yong RN,Gibbs BF.Remediation technologies for metal-contaminated soils and groundwater:an evaluation [J].Eng Geol,2001,60:193-207.
  • 4Mulligan CN.Environmental applications for biosurfactants [J].Environ Pollut,2005,133:183-198.
  • 5Sun XX,Choi JK,Kim EK.A preliminary study on the mechanism of harmful algal bloom mitigation by use of sophorolipid treatment [J].J Exp Mar Biol Ecol,2004a,304:35-49.
  • 6Sun XX,Lee YJ,Choi JK,Kim EK.Synergistic effect of sophorolipid and loess combination in harmful algal blooms mitigation [J].Mar Pollut Bull,2004b,48:863-872.
  • 7Singh P,Cameotra SS.Potential applications of microbial surfactants in biomedical sciences [J].TRENDS in Biotechnol,2004,22:142-146.
  • 8Cameotra SS,Makkar RS.Recent applications of biosurfactants as biological and immunological molecules [J].Curr Opin Microbiol,2004,7:262-266.
  • 9Isoda H,Kitamoto D,Shinmoto H,Matsumoto M,Nakahara T.Microbial extracellular glycolipid induction of differentiation and inhibition of protein kinase C activity of human promyelocytic leukemia cell line HL60 [J].Biosci Biotechnol Biochem,1997,61:609-614.
  • 10Scholz C,Mehta S,Bisht K.Bioactivity of extracellular glycolipids-investigation of potentional anticancer activity of sophorolipids and sophorolipid-derivatives [J].Polym Prepr,1998,39:168-169.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部